ArticleACS medicinal chemistry letters2014

Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of Action.

Michael J Stocks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.